Article info
PDFOriginal research
How should we think about clinical data ownership?
- Correspondence to Dr Angela Ballantyne, Department of Primary Health Care and General Practice and the Bioethics Center, Otago University, Wellington, New Zealand; angela.ballantyne{at}otago.ac.nz
Citation
How should we think about clinical data ownership?
Publication history
- Received December 27, 2018
- Revised August 27, 2019
- Accepted November 1, 2019
- First published January 7, 2020.
Online issue publication
May 14, 2020
Article Versions
- Previous version (7 January 2020).
- Previous version (23 January 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Other content recommended for you
- Control, trust and the sharing of health information: the limits of trust
- Patients’ and public views and attitudes towards the sharing of health data for research: a narrative review of the empirical evidence
- Can the NHS be a learning healthcare system in the age of digital technology?
- 'It’s not something you can take in your hands'. Swiss experts’ perspectives on health data ownership: an interview-based study
- Webinar report: stakeholder perspectives on informed consent for the use of genomic data by commercial entities
- Sharing and reuse of individual participant data from clinical trials: principles and recommendations
- Meta consent: a flexible and autonomous way of obtaining informed consent for secondary research
- Participatory governance over research in an academic research network: the case of Diabetes Action Canada
- Improving services with informatics tools
- Using routine data to improve palliative and end of life care